Cognex Corporation

CGNX Technology Scientific & Technical Instruments

Cognex Corporation’s revenue for fiscal 2025 (year ended December 2025) was $994.4 million, up 8.73% from fiscal 2024. In the quarter to June 2026, revenue grew 16.9%, EPS grew 79.2% and free cash flow grew 67.3%, each against the same quarter a year earlier. Dividend growth for five consecutive years.

54.11 1.56 −2.80%
Market cap
$9.4B
P/E
51.5×
Fwd P/E
42.7×
Dividend yield
0.63%
F-score
8/9
Altman Z
8.26
Beneish M
−2.78
Dividend safety
84/100

Insider Decisions trades per month

Total sells 34.77
Totals in millions of $.
Dec 25 Mar 26 Jun 26 Sep 26
Buy — — — — — — — — — — — —
Sell — — — 6 1 — 3 — — 1 — —
Insider Ownership 0.00%

Capital & Financial Ratios $m

Market Cap 9,370.00
Revenue 1,088.93
Net Income 174.79
Free Cash Flow 275.00
Net Debt (404.37)
Current Ratio 3.93 (at or above 1.5: strong)
Debt/Equity 0.00 (at or below 0.5: strong)
P/E ratio 51.53 (above 35: high)
Fwd P/E 42.70 (above 35: high)
P/S ratio 8.32
P/B ratio 5.56
Past 5Y EPS Growth (7.42%) (below 0%: weak)
This Y EPS Growth 65.02% (at or above 15%: strong)
Next Y EPS Growth 17.87% (at or above 15%: strong)
Next Y revenue growth 15.25% (at or above 10%: strong)
Next 5Y EPS Growth 30.58% (at or above 15%: strong)

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

P/E against its own 10 years 58.64%
10-year low 10-year high
P/S against its own 10 years 30.26%
10-year low 10-year high
P/B against its own 10 years 34.06%
10-year low 10-year high
EV/Sales against its own 10 years 31.22%
10-year low 10-year high
EV/FCF against its own 10 years 16.62%
10-year low 10-year high

Dividends

Payout Ratio 0.33
Annual Dividend Rate 0.34
Annual Dividend Yield 0.63%
total individual payouts
2028 Powerpack
2027 Powerpack
2026 0.34
0.09
0.09
0.09
2025 0.33
0.08
0.08
0.08
0.09
2024 0.31
0.08
0.08
0.08
0.08
2023 0.29
0.07
0.07
0.07
0.08
2022 0.27
0.07
0.07
0.07
0.07
2021 0.25
0.06
0.06
0.06
0.07
2020 0.23
0.06
0.06
0.06
0.06
2.00
2019 0.21
0.05
0.05
0.05
0.06
2018 0.19
0.05
0.05
0.05
0.05
2017 0.17
0.04
0.04
0.04
0.05
2016 0.15
0.04
0.04
0.04
0.04
predictions special payouts not included in total or ratios

Assets vs Liabilities $m

2023 2024 2025 Q'26
Cash 332 246 337 404
Receivables 114 143 147 216
Inventory 162 158 138 143
Other 2 3 17 13
679 613 697 850
2023 2024 2025 Q'26
Payables 21 38 50 65
ST’ Debt — — — —
Other — — — —
152 169 184 216

Compound Annual Growth %

10y 5y 3y
Sales 8.24% 4.16% (0.39%)
Cash Flow 6.70% 0.26% 0.29%
Earnings (4.80%) (8.27%) (19.02%)
Book Value 6.09% 3.40% 1.22%

Revenue $m

Mar Jun Sep Dec Year
’26 268 291 — — —
’25 216 249 277 252 994
’24 211 239 235 230 915
’23 201 243 197 197 838
’22 282 275 210 239 1,006
’21 239 269 285 244 1,037
’20 167 169 251 224 811
Fiscal quarters ending in the months shown.

Operating Cash Flow $m

Mar Jun Sep Dec Year
’26 45 69 — — —
’25 41 43 87 75 246
’24 14 28 56 51 149
’23 28 30 41 14 113
’22 50 44 84 66 243
’21 99 96 64 55 314
’20 62 14 83 83 242
Fiscal quarters ending in the months shown.

Free Cash Flow $m

Mar Jun Sep Dec Year
’26 42 68 — — —
’25 38 40 86 79 243
’24 10 23 52 49 134
’23 22 25 35 7 90
’22 45 37 79 62 224
’21 96 92 60 50 299
’20 59 10 80 79 229
Fiscal quarters ending in the months shown.

EPS $

Mar Jun Sep Dec Year
’26 0.31 0.43 — — —
’25 0.14 0.24 0.10 0.19 0.68
’24 0.07 0.21 0.17 0.16 0.62
’23 0.15 0.33 0.11 0.07 0.65
’22 0.38 0.34 0.19 0.32 1.23
’21 0.39 0.43 0.44 0.30 1.56
’20 0.12 (0.01) 0.49 0.39 1.00
Fiscal quarters ending in the months shown.

Target Price Range

Analyst price targets

Recommendation Rating

1.8
1Buy 2 3Hold 4 5Sell

Ten years at a glance Fiscal years to December

Group Line 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 Trend 2026e 2027e 2028e
Price, $
Price, $ Low 14.01 31.18 34.88 35.60 35.20 72.85 40.21 34.28 34.79 22.67

Analyst estimates 2026–2028

Powerpack
High 32.98 72.99 70.00 57.31 83.10 101.82 80.30 59.51 53.13 49.76
People
People Employees 1,421 1,771 2,124 2,267 2,055 2,257 2,441 2,992 2,914 2,745
Revenue/emp, $m 0.37 0.43 0.38 0.32 0.39 0.46 0.41 0.28 0.31 0.36
Income, $m
Income, $m Revenue 530 766 806 726 811 1,037 1,006 838 915 994
Gross margin, % 75.25 75.55 74.45 73.85 74.55 73.26 71.75 71.79 68.43 66.92
EBT 162 266 235 163 187 319 251 135 131 183
EBT margin, % 30.61 34.78 29.09 22.46 23.05 30.75 24.92 16.16 14.38 18.38
Net income 144 177 219 204 176 280 216 113 106 114
Depreciation 15 17 22 24 28 25 25 24 33 30
Per share, $
Per share, $ Revenue 3.10 4.42 4.68 4.24 4.67 5.88 5.80 4.86 5.33 5.92
Earnings 0.88 1.02 1.27 1.19 1.02 1.59 1.24 0.66 0.62 0.68
Cash flow 1.07 1.29 1.30 1.48 1.40 1.78 1.40 0.66 0.87 1.46
Capex (0.08) (0.17) (0.22) (0.13) (0.08) (0.09) (0.11) (0.13) (0.09) (0.01)
Free cash flow 0.99 1.13 1.08 1.35 1.32 1.69 1.29 0.52 0.78 1.45
Book value 5.64 6.32 6.59 7.92 7.28 8.10 8.29 8.74 8.85 8.88
Shares, m 171 173 172 171 173 176 173 172 171 168
Valuation, ×
Valuation, × P/E 35.95 60.18 30.45 47.49 79.23 48.91 38.34 61.12 57.84 52.14
P/S 10.20 13.88 8.26 13.22 17.18 13.23 8.26 8.30 6.72 6.08
P/B 5.61 9.71 5.87 7.08 11.04 9.60 5.78 4.62 4.05 4.05
EV/Sales 9.40 13.36 7.60 12.65 16.72 12.92 7.86 7.90 6.45 5.74
EV/FCF 31.36 55.28 34.84 41.53 62.01 46.50 37.09 83.37 47.76 24.50
Cash, $m
Cash, $m Operating cash flow 182 224 223 253 242 314 243 113 149 246
Capex (13) (29) (37) (22) (13) (15) (20) (23) (15) (2)
Free cash flow 169 196 186 232 229 299 224 90 134 243
Balance, $m
Balance, $m Working capital 461 517 689 487 469 451 530 527 444 514
Total debt — — — 18 26 26 39 — — —
Net debt (421) (405) (536) (412) (372) (324) (400) (332) (246) (337)
Shareholders’ equity 963 1,096 1,135 1,356 1,262 1,430 1,438 1,505 1,518 1,492
Returns, %
Returns, % ROA 14.92 15.19 17.01 12.84 9.56 14.71 10.88 5.70 5.29 5.71
ROIC 17.77 23.41 23.05 9.44 11.98 17.80 14.82 6.97 5.66 8.80
ROE 16.07 17.17 19.66 16.37 13.46 20.79 15.03 7.69 7.03 7.61
Negative figures in brackets.

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Charts ten years each

Cognex Corporation vs peers in Scientific & Technical Instruments (Q) = latest quarter vs a year earlier

Company Market cap P/E Fwd P/E Revenue growth (Q) EPS growth (Q) FCF growth (Q) Gross margin (Q) EBIT margin (Q) Compare
FTV Fortive Corporation $17.5B 33.6× 30.8× +7.91% (above 0%: growing) +6.12% (above 0%: growing) −9.82% (below 0%: shrinking) 63.39% 19.14% Compare
MKSI MKS Inc. $15.5B 32.9× 37.4× +28.26% (above 0%: growing) +181.52% (above 0%: growing) +38.97% (above 0%: growing) 47.68% 20.11% Compare
TRMB Trimble Inc. $14.2B — (loss-making) 24.1× +11.00% (above 0%: growing) n/m +492.59% (above 0%: growing) 69.43% 13.58% Compare
CGNX Cognex Corporation $9.4B 51.5× 42.7× +16.93% (above 0%: growing) +79.17% (above 0%: growing) +67.25% (above 0%: growing) 70.65% 29.36%
ESE ESCO Technologies Inc. $7.8B 20.5× 46.9× +14.40% (above 0%: growing) +24.75% (above 0%: growing) −22.12% (below 0%: shrinking) 41.74% 14.80% Compare
ST Sensata Technologies Holding N.V. $6.0B 66.5× 16.9× +5.00% (above 0%: growing) +70.73% (above 0%: growing) +61.39% (above 0%: growing) 30.47% 16.70% Compare
NOVT Novanta Inc. $5.1B 81.0× 62.9× +10.27% (above 0%: growing) +158.33% (above 0%: growing) +391.84% (above 0%: growing) 45.49% 6.79% Compare
VNT Vontier Corporation $4.5B 13.7× 8.6× −2.17% (below 0%: shrinking) −67.74% (below 0%: shrinking) +13.79% (above 0%: growing) 48.24% 19.39% Compare
ITRI Itron, Inc. $3.7B 13.6× 15.4× −7.23% (below 0%: shrinking) −19.33% (below 0%: shrinking) −10.13% (below 0%: shrinking) 40.97% 13.51% Compare
Median of peers $6.9B 32.9× 27.5× +9.09% +24.75% +26.38% 46.59% 15.75%

All 34 Scientific & Technical Instruments stocks →

Cognex Corporation (CGNX) key facts

  • Strength: Cognex Corporation’s revenue for fiscal 2025 (year ended December 2025) was $994.4 million, up 8.73% from fiscal 2024.
  • Cognex Corporation (CGNX) is a Scientific & Technical Instruments company in the Technology sector, listed on Nasdaq.
  • As of October 16, 2026, CGNX traded at $54.11, a market capitalization of $9.4 billion.
  • Cognex Corporation pays an annual dividend of $0.34 per share, a yield of 0.63%, with a payout ratio of 33.0%.
  • Return on equity was 7.61% and debt-to-equity 0.00.
  • Its Piotroski F-score is 8 out of 9 and its Altman Z-score is 8.26 (safe zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations.

Cognex Corporation (CGNX) Latest News

12 Aug

Impact 3 · transcript
stockrow.com/CGNX · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com